Compounding Updates: GLP-1 503B Bulks List & Peptides Evaluation

Recent FDA proposals and interim bulks list updates signal a clear trend toward tighter control of compounding in these high-demand therapeutic categories. As of 2026, this shift is no longer speculative but is actively unfolding through proposed exclusions, advisory committee reviews, and reclassification of multiple peptide bulk drug substances. Together, these actions are creating a more defined and restrictive framework for how certain medications can be compounded, sourced, and prescribed.

503BAna AleksicMay 18, 2026503B

Med Spa & Pharmacy Compounded Medication Due Diligence

Medication sourcing in aesthetic and wellness medicine increasingly sits at the intersection of medical spas, 503A compounding pharmacies, and 503B outsourcing facilities. Each plays a distinct but interconnected role in the supply chain. While compounding plays an essential role when commercially available products do not meet clinical needs, it also introduces additional layers of complexity. As a result, structured supplier due diligence is no longer optional.

503BAna AleksicMay 18, 2026503B, 503B Outsourcing, Med Spa

CQV Explained: A Practical Guide for Pharma, 503Bs & CGT

Getting CQV right ensures your systems, processes, and people consistently deliver safe, high-quality products while maintaining regulatory compliance. This guide breaks down key CQV definitions, processes, and regulations for pharmaceutical and life science companies.

CQV, 503BAna AleksicFebruary 9, 2026cGMP

Personalized Hormone Therapy & The Menopause Care Gap

As FDA labeling evolves, telehealth scales, and demand for customized hormone therapy grows, pharmacies and outsourcing facilities face new expectations. The next era of menopause care will depend on infrastructure capable of supporting consistent, well-coordinated, personalized hormone therapy services at scale. Here’s what every 503A pharmacy, 503B outsourcing facility, and telehealth organization needs to anticipate next.

503A, 503BAna AleksicDecember 9, 2025cHRT, Menopause, Compounding, Pharmacy Compounding, Telehealth

Compounding Pharmacy and Outsourcing Facility Cleanroom Design and Construction Principles

Cleanrooms must be purpose-built in order to achieve regulatory compliance and quality assurance. A retail pharmacy with plans to squeeze in a small area to prepare TPN or specialty IV compounds may find out the hard way that there was not enough space allotted to promote operational efficiencies. Similarly, a 503A pharmacy looking to convert to a 503B outsourcing facility may be in for a rude awakening to learn that cleanroom designs and space requirements are vastly different for each entity. However, the following principles hold true for most cleanroom layout design and cleanroom construction planning:

503A, 503BAmy SummersMarch 18, 2022CleanroomDesign, CleanroomConstruction

503A + 503B Compounding News

© 2019-2026 restore

Info

Action